{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:44:12Z","timestamp":1740149052967,"version":"3.37.3"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T00:00:00Z","timestamp":1651708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T00:00:00Z","timestamp":1651708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["212946\/Z\/18\/Z","202922\/Z\/16\/Z","104085\/Z\/14\/Z","088158\/Z\/09\/Z"],"award-info":[{"award-number":["212946\/Z\/18\/Z","202922\/Z\/16\/Z","104085\/Z\/14\/Z","088158\/Z\/09\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC-PC-13049","MC-PC-14135","MC_UU_00017\/1","MC_UU_12026\/2","MC_U137686851"],"award-info":[{"award-number":["MC-PC-13049","MC-PC-14135","MC_UU_00017\/1","MC_UU_12026\/2","MC_U137686851"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer research UK","doi-asserted-by":"crossref","award":["C16077\/A29186","C500\/A16896"],"award-info":[{"award-number":["C16077\/A29186","C500\/A16896"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000274","name":"British heart foundation","doi-asserted-by":"crossref","award":["CH\/1996001\/9454"],"award-info":[{"award-number":["CH\/1996001\/9454"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91843302"],"award-info":[{"award-number":["91843302"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Research and Development Program of China","award":["2016YFC0900500","2016YFC0900501","2016YFC0900504","2016YFC1303904"],"award-info":[{"award-number":["2016YFC0900500","2016YFC0900501","2016YFC0900504","2016YFC1303904"]}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. of Cardiovasc. Trans. Res."],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Tissue remodelling and fibrosis which occur in response to injury play a central role in the development of many diseases. Chymase is a key enzyme believed to mediate these pathological processes. As such, chymase inhibitors have been under active development for the treatment of a number of conditions. To investigate the impact of reduced chymase function, we constructed a genetic score from two pLoF mutations in the gene encoding chymase and tested its association with diseases and biomarkers. Our study found no association between the genetically-predicted reduced chymase function score and heart failure, chronic kidney disease or other predefined conditions. We additionally found no association of the score with any physical measurements or biomarkers. Our results provide no evidence in support of chymase inhibition as a novel therapeutic strategy for the treatment or prevention of heart failure, chronic kidney disease or major cardiovascular events, as previously proposed.<\/jats:p>","DOI":"10.1007\/s12265-022-10261-w","type":"journal-article","created":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T16:08:36Z","timestamp":1651766916000},"page":"1474-1476","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigation into the Health Effects of Reduced Chymase Function Using Predicted Loss-of-Function Mutations in CMA1"],"prefix":"10.1007","volume":"15","author":[{"given":"Zammy","family":"Fairhurst-Hunter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin G.","family":"Walters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Zink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Canqing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel F.","family":"Freitag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iona Y.","family":"Millwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,5]]},"reference":[{"key":"10261_CR1","doi-asserted-by":"publisher","unstructured":"Kanefendt, F., Thu\u00df, U., Becka, M., et al., (2019). Pharmacokinetics, safety, and tolerability of the novel chymase inhibitor BAY 1142524 in healthy male volunteers. Clin Pharmacol Drug Dev, 467\u2013479 https:\/\/doi.org\/10.1002\/cpdd.579","DOI":"10.1002\/cpdd.579"},{"key":"10261_CR2","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1159\/000506985","volume":"12","author":"G Pejler","year":"2020","unstructured":"Pejler, G. (2020). Novel insight into the in vivo function of mast cell chymase: Lessons from knockouts and inhibitors. Journal of Innate Immunity, 12, 357\u2013372.","journal-title":"Journal of Innate Immunity"},{"key":"10261_CR3","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1093\/ije\/dyr120","volume":"40","author":"Z Chen","year":"2011","unstructured":"Chen, Z., Chen, J., Collins, R., et al. (2011). China Kadoorie Biobank of 0.5 million people: Survey methods, baseline characteristics and long-term follow-up. International Journal of Epidemiology, 40, 1652\u20131666. https:\/\/doi.org\/10.1093\/ije\/dyr120","journal-title":"International Journal of Epidemiology"},{"key":"10261_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-019-01300-7","volume":"19","author":"D Zhou","year":"2019","unstructured":"Zhou, D., Chen, Y., Wu, J., et al. (2019). Association between chymase gene polymorphisms and atrial fibrillation in Chinese Han population. BMC Cardiovascular Disorders, 19, 1\u20135. https:\/\/doi.org\/10.1186\/s12872-019-01300-7","journal-title":"BMC Cardiovascular Disorders"},{"key":"10261_CR5","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.humimm.2010.08.008","volume":"71","author":"M Hersberger","year":"2010","unstructured":"Hersberger, M., Thun, G. A., Imboden, M., et al. (2010). Association of STR polymorphisms in CMA1 and IL-4 with asthma and atopy: The SAPALDIA cohort. Human Immunology, 71, 1154\u20131160. https:\/\/doi.org\/10.1016\/j.humimm.2010.08.008","journal-title":"Human Immunology"}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-022-10261-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12265-022-10261-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-022-10261-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T17:47:07Z","timestamp":1670262427000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12265-022-10261-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,5]]},"references-count":5,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10261"],"URL":"https:\/\/doi.org\/10.1007\/s12265-022-10261-w","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"type":"print","value":"1937-5387"},{"type":"electronic","value":"1937-5395"}],"subject":[],"published":{"date-parts":[[2022,5,5]]},"assertion":[{"value":"8 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The China Kadoorie Biobank (CKB) complies with all the required ethical standards for medical research on human subjects. Ethical approvals were granted and have been maintained by the relevant institutional ethical research committees in the UK and China. Informed consent was obtained from all participants included in the study. No animal studies were carried out by the authors for this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to Participate"}},{"value":"Drs. Freitag and Zink are employees of Bayer AG. No other disclosures were reported.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}